VF
NEO icon

Virtu Financial’s NeoGenomics NEO Stock Holding History

Virtu Financial’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,234
Closed -$150K – 2022
2026
Q1 		$150K Buy
+20,234
New +$213K 0.01% 1103
2025
Q4 		– Sell
-28,987
Closed -$224K – 2039
2025
Q3 		$224K Buy
28,987
+16,991
+142% +$119K 0.01% 867
2025
Q2 		$88K Buy
+11,996
New +$96.8K ﹤0.01% 1055
2023
Q2 		– Sell
-17,404
Closed -$303K – 1850
2023
Q1 		$303K Buy
+17,404
New +$248K 0.03% 544
2022
Q2 		– Sell
-37,001
Closed -$450K – 1903
2022
Q1 		$450K Buy
37,001
+28,752
+349% +$605K 0.03% 429
2021
Q4 		$281K Buy
+8,249
New +$323K 0.03% 662
2019
Q4 		– Sell
-15,284
Closed -$292K – 1708
2019
Q3 		$292K Buy
15,284
+2,839
+23% +$66.6K 0.02% 777
2019
Q2 		$273K Buy
+12,445
New +$273K 0.02% 835

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Virtu Financial's NEO Position: Q2 2026 in Review

Virtu Financial sold out of NeoGenomics (NEO) in Q2 2026, closing a stake of 20,234 shares — an estimated $150K sold.

Virtu Financial first reported a position in NEO in Q2 2019 and held it in 8 quarters. The position peaked at $450K in Q1 2022. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Virtu Financial reported no remaining NeoGenomics position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 20,234 NeoGenomics shares in Q2 2026, an estimated $150K.
  • Virtu Financial first reported a position in NeoGenomics in Q2 2019 and held it in 8 quarters.
  • Virtu Financial's NeoGenomics position peaked at $450K in Q1 2022.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.